Global EPA and DHA Formula Market Growth 2024-2030

Publication ID:

LPI03250473

Publication Date:

March 18, 2025

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global EPA and DHA Formula market size is predicted to grow from US$ 3660 million in 2024 to US$ 5747 million in 2030; it is expected to grow at a CAGR of 7.8% from 2024 to 2030.
EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) are two important omega-3 polyunsaturated fatty acids, mainly found in marine organisms (such as fish) and some algae. They play a vital role in human health, especially in cardiovascular health, brain function and anti-inflammation. EPA and DHA formula usually refers to dietary supplements or products containing EPA and DHA, which are generally derived from fish oil, algae oil or other oils rich in omega-3.
The EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) formula market is experiencing robust growth, driven by increasing consumer awareness of the health benefits associated with omega-3 fatty acids, including cardiovascular, cognitive, and anti-inflammatory support. Demand is fueled by a growing focus on preventive healthcare, rising cases of chronic diseases, and expanding applications in dietary supplements, functional foods, pharmaceuticals, and infant nutrition. Plant-based and algal-derived sources are gaining traction alongside traditional fish oil formulations, catering to vegetarians, vegans, and sustainability-conscious consumers. North America and Europe dominate the market due to high health awareness and established dietary supplement industries, while the Asia-Pacific region presents significant growth opportunities due to rising disposable incomes and nutritional education. Manufacturers are focusing on product innovation, purity standards, and sustainability to meet regulatory requirements and evolving consumer preferences.
The 鈥淓PA and DHA Formula Industry Forecast鈥� looks at past sales and reviews total world EPA and DHA Formula sales in 2023, providing a comprehensive analysis by region and market sector of projected EPA and DHA Formula sales for 2024 through 2030. With EPA and DHA Formula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EPA and DHA Formula industry.
This Insight Report provides a comprehensive analysis of the global EPA and DHA Formula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EPA and DHA Formula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global EPA and DHA Formula market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EPA and DHA Formula and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EPA and DHA Formula.
This report presents a comprehensive overview, market shares, and growth opportunities of EPA and DHA Formula market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
From Plants
From Animals
Segmentation by Application:
Online Sales
Offline Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Now
Jarrow Formulas
Ross J. Barr
Puori
Thorne
Youtheory
Perelel
Efamol
Lepivits
Metagenics
Doctor's Nutrition
Nature's Way Products
Key Questions Addressed in this Report
What is the 10-year outlook for the global EPA and DHA Formula market?
What factors are driving EPA and DHA Formula market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EPA and DHA Formula market opportunities vary by end market size?
How does EPA and DHA Formula break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global EPA and DHA Formula Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for EPA and DHA Formula by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for EPA and DHA Formula by Country/Region, 2019, 2023 & 2030
2.2 EPA and DHA Formula Segment by Type
2.2.1 From Plants
2.2.2 From Animals
2.3 EPA and DHA Formula Sales by Type
2.3.1 Global EPA and DHA Formula Sales Market Share by Type (2019-2024)
2.3.2 Global EPA and DHA Formula Revenue and Market Share by Type (2019-2024)
2.3.3 Global EPA and DHA Formula Sale Price by Type (2019-2024)
2.4 EPA and DHA Formula Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 EPA and DHA Formula Sales by Application
2.5.1 Global EPA and DHA Formula Sale Market Share by Application (2019-2024)
2.5.2 Global EPA and DHA Formula Revenue and Market Share by Application (2019-2024)
2.5.3 Global EPA and DHA Formula Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global EPA and DHA Formula Breakdown Data by Company
3.1.1 Global EPA and DHA Formula Annual Sales by Company (2019-2024)
3.1.2 Global EPA and DHA Formula Sales Market Share by Company (2019-2024)
3.2 Global EPA and DHA Formula Annual Revenue by Company (2019-2024)
3.2.1 Global EPA and DHA Formula Revenue by Company (2019-2024)
3.2.2 Global EPA and DHA Formula Revenue Market Share by Company (2019-2024)
3.3 Global EPA and DHA Formula Sale Price by Company
3.4 Key Manufacturers EPA and DHA Formula Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers EPA and DHA Formula Product Location Distribution
3.4.2 Players EPA and DHA Formula Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for EPA and DHA Formula by Geographic Region
4.1 World Historic EPA and DHA Formula Market Size by Geographic Region (2019-2024)
4.1.1 Global EPA and DHA Formula Annual Sales by Geographic Region (2019-2024)
4.1.2 Global EPA and DHA Formula Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic EPA and DHA Formula Market Size by Country/Region (2019-2024)
4.2.1 Global EPA and DHA Formula Annual Sales by Country/Region (2019-2024)
4.2.2 Global EPA and DHA Formula Annual Revenue by Country/Region (2019-2024)
4.3 Americas EPA and DHA Formula Sales Growth
4.4 APAC EPA and DHA Formula Sales Growth
4.5 Europe EPA and DHA Formula Sales Growth
4.6 Middle East & Africa EPA and DHA Formula Sales Growth
5 Americas
5.1 Americas EPA and DHA Formula Sales by Country
5.1.1 Americas EPA and DHA Formula Sales by Country (2019-2024)
5.1.2 Americas EPA and DHA Formula Revenue by Country (2019-2024)
5.2 Americas EPA and DHA Formula Sales by Type (2019-2024)
5.3 Americas EPA and DHA Formula Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC EPA and DHA Formula Sales by Region
6.1.1 APAC EPA and DHA Formula Sales by Region (2019-2024)
6.1.2 APAC EPA and DHA Formula Revenue by Region (2019-2024)
6.2 APAC EPA and DHA Formula Sales by Type (2019-2024)
6.3 APAC EPA and DHA Formula Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe EPA and DHA Formula by Country
7.1.1 Europe EPA and DHA Formula Sales by Country (2019-2024)
7.1.2 Europe EPA and DHA Formula Revenue by Country (2019-2024)
7.2 Europe EPA and DHA Formula Sales by Type (2019-2024)
7.3 Europe EPA and DHA Formula Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa EPA and DHA Formula by Country
8.1.1 Middle East & Africa EPA and DHA Formula Sales by Country (2019-2024)
8.1.2 Middle East & Africa EPA and DHA Formula Revenue by Country (2019-2024)
8.2 Middle East & Africa EPA and DHA Formula Sales by Type (2019-2024)
8.3 Middle East & Africa EPA and DHA Formula Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of EPA and DHA Formula
10.3 Manufacturing Process Analysis of EPA and DHA Formula
10.4 Industry Chain Structure of EPA and DHA Formula
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 EPA and DHA Formula Distributors
11.3 EPA and DHA Formula Customer
12 World Forecast Review for EPA and DHA Formula by Geographic Region
12.1 Global EPA and DHA Formula Market Size Forecast by Region
12.1.1 Global EPA and DHA Formula Forecast by Region (2025-2030)
12.1.2 Global EPA and DHA Formula Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global EPA and DHA Formula Forecast by Type (2025-2030)
12.7 Global EPA and DHA Formula Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Now
13.1.1 Now Company Information
13.1.2 Now EPA and DHA Formula Product Portfolios and Specifications
13.1.3 Now EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Now Main Business Overview
13.1.5 Now Latest Developments
13.2 Jarrow Formulas
13.2.1 Jarrow Formulas Company Information
13.2.2 Jarrow Formulas EPA and DHA Formula Product Portfolios and Specifications
13.2.3 Jarrow Formulas EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Jarrow Formulas Main Business Overview
13.2.5 Jarrow Formulas Latest Developments
13.3 Ross J. Barr
13.3.1 Ross J. Barr Company Information
13.3.2 Ross J. Barr EPA and DHA Formula Product Portfolios and Specifications
13.3.3 Ross J. Barr EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Ross J. Barr Main Business Overview
13.3.5 Ross J. Barr Latest Developments
13.4 Puori
13.4.1 Puori Company Information
13.4.2 Puori EPA and DHA Formula Product Portfolios and Specifications
13.4.3 Puori EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Puori Main Business Overview
13.4.5 Puori Latest Developments
13.5 Thorne
13.5.1 Thorne Company Information
13.5.2 Thorne EPA and DHA Formula Product Portfolios and Specifications
13.5.3 Thorne EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Thorne Main Business Overview
13.5.5 Thorne Latest Developments
13.6 Youtheory
13.6.1 Youtheory Company Information
13.6.2 Youtheory EPA and DHA Formula Product Portfolios and Specifications
13.6.3 Youtheory EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Youtheory Main Business Overview
13.6.5 Youtheory Latest Developments
13.7 Perelel
13.7.1 Perelel Company Information
13.7.2 Perelel EPA and DHA Formula Product Portfolios and Specifications
13.7.3 Perelel EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Perelel Main Business Overview
13.7.5 Perelel Latest Developments
13.8 Efamol
13.8.1 Efamol Company Information
13.8.2 Efamol EPA and DHA Formula Product Portfolios and Specifications
13.8.3 Efamol EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Efamol Main Business Overview
13.8.5 Efamol Latest Developments
13.9 Lepivits
13.9.1 Lepivits Company Information
13.9.2 Lepivits EPA and DHA Formula Product Portfolios and Specifications
13.9.3 Lepivits EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Lepivits Main Business Overview
13.9.5 Lepivits Latest Developments
13.10 Metagenics
13.10.1 Metagenics Company Information
13.10.2 Metagenics EPA and DHA Formula Product Portfolios and Specifications
13.10.3 Metagenics EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Metagenics Main Business Overview
13.10.5 Metagenics Latest Developments
13.11 Doctor's Nutrition
13.11.1 Doctor's Nutrition Company Information
13.11.2 Doctor's Nutrition EPA and DHA Formula Product Portfolios and Specifications
13.11.3 Doctor's Nutrition EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Doctor's Nutrition Main Business Overview
13.11.5 Doctor's Nutrition Latest Developments
13.12 Nature's Way Products
13.12.1 Nature's Way Products Company Information
13.12.2 Nature's Way Products EPA and DHA Formula Product Portfolios and Specifications
13.12.3 Nature's Way Products EPA and DHA Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Nature's Way Products Main Business Overview
13.12.5 Nature's Way Products Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂